Mota, Talia

Publications

Sort by

Co-Author Network

selected publications

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses. bioRxiv : the preprint server for biology. 2023 Article GET IT
CD8⁺ T cells promote HIV latency by remodeling CD4⁺ T cell metabolism to enhance their survival, quiescence, and stemness. Immunity. 2023 Academic Article GET IT
Times cited: 1
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins. Proceedings of the National Academy of Sciences of the United States of America. 2022 Academic Article GET IT
Times cited: 4
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins. bioRxiv : the preprint server for biology. 2022 Article GET IT
Times cited: 66
Selective BCL-X_L Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs. Journal of virology. 2021 Academic Article GET IT
Times cited: 6
A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies. The Journal of experimental medicine. 2021 Academic Article GET IT
Times cited: 4
Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature communications. 2021 Article GET IT
Times cited: 1
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy. JCI insight. 2021 Academic Article GET IT
Times cited: 22
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature communications. 2021 Academic Article GET IT
Times cited: 29
Immunological approaches to HIV cure. Seminars in immunology. 2020 Review GET IT
Times cited: 32
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 47
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8⁺ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal. Journal of virology. 2020 Academic Article GET IT
Times cited: 17
HTLV-1 as a Model for Virus and Host Coordinated Immunoediting. Frontiers in immunology. 2019 Academic Article GET IT
Times cited: 7
Have Cells Harboring the HIV Reservoir Been Immunoedited?. Frontiers in immunology. 2019 Academic Article GET IT
Times cited: 12
Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs. Journal of virology. 2019 Academic Article GET IT
Times cited: 15
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nature communications. 2019 Academic Article GET IT
Times cited: 107
Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 2018 Academic Article GET IT
Times cited: 1
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy. AIDS research and human retroviruses. 2018 Academic Article GET IT
Times cited: 4
Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 2018 Academic Article GET IT
Times cited: 33
HLA-C downregulation by HIV-1 adapts to host HLA genotype. PLoS pathogens. 2018 Academic Article GET IT
Times cited: 17
Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4⁺ T Cells. Journal of immunology (Baltimore, Md. : 1950). 2018 Academic Article GET IT
Times cited: 13
HIV latency reversing agents act through Tat post translational modifications. Retrovirology. 2018 Academic Article GET IT
Times cited: 21
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy. AIDS (London, England). 2017 Academic Article GET IT
Times cited: 9
Differentiating founder and chronic HIV envelope sequences. PloS one. 2017 Academic Article GET IT
Times cited: 2
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB. Retrovirology. 2016 Academic Article GET IT
Times cited: 25
Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro. PloS one. 2016 Academic Article GET IT
Times cited: 7
Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy. PloS one. 2014 Academic Article GET IT
Times cited: 20
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission. Retrovirology. 2012 Academic Article GET IT
Times cited: 5

more ...

less ...

Background

education and training

Ph.D., University of Melbourne (Australia) 2018
M.P.H., University of Melbourne (Australia) 2010
B.S., University of California, Davis 2005

Contact

full name

Talia Mota

primary email

tam2036@med.cornell.edu

VIVO Weill Cornell Medical College

Talia Mota Postdoctoral Associate in Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email